Absci Corporation (ABSI) Dividend History

Absci Corporation is a biotechnology company specializing in artificial intelligence-driven drug discovery and development. It leverages its proprietary platform to streamline the creation of biologics and identify new therapeutic candidates efficiently, aiming to accelerate the journey from discovery to clinical trials.

18105 Se Mill Plain Blvd, Vancouver, WA, 98683
Phone: (360) 949-1041
Website: https://www.absci.com

Dividend History

Absci Corporation currently does not pay dividends

Company News

  • Absci to Participate in Upcoming Investor Conferences

    Absci Corporation announced participation in upcoming healthcare investor conferences and highlighted its AI-driven drug discovery platform, focusing on innovative therapeutics like ABS-101 for inflammatory bowel disease and ABS-201 for hair regrowth.

    GlobeNewswire Inc.
  • Absci Announces Pricing of Public Offering of Common Stock

    Absci Corporation announced a public offering of 16,670,000 shares of common stock at $3.00 per share, expecting to raise approximately $50 million to fund drug development programs and corporate purposes.

    Benzinga
    Featured Companies: MS
  • 4 Biotech Stocks With AI, Machine Learning Prowess

    The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.

    Investing.com
    Featured Companies: AIFF KRRO NRSN
  • Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

    Cathie Wood's Ark Invest has been buying shares of Tempus AI, Blade Air Mobility, and Absci despite a rough year for growth investors. Tempus AI and Absci are using AI for healthcare solutions, while Blade Air Mobility operates a helicopter transport service.

    The Motley Fool
    Featured Companies: BLDE TEM
  • Absci (ABSI) to Report Q1 Earnings: Here's What to Expect

    The focus is likely to be on progress on its pipeline candidates when generative AI drug creation company Absci (ABSI) reports first-quarter results.

    Zacks Investment Research
    Featured Companies: ADVM ANIP ARVN
Page data last updated 09/06/2025 03:39:21 UTC